Nick DeGraan-Weber

Publications

100

Citations

H-Index

2016

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Amgen (United States)

AstraZeneca (United States)

Novo Nordisk (Denmark)

United States Food and Drug Administration

Nick DeGraan-Weber is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in biological mass spectrometry, mass spectrometry, and medicine.

Top concepts

MedicineProteomicsMass SpectrometryBiological Mass SpectrometryOmicsChemistryManagementStatisticsBioanalysisData Mining

Publications per year

2016–2022

Publications

New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study

Trina Mouchahoir, John E. Schiel, Rich Rogers et al. · Journal of the American Society for Mass Spectrometry · 2021 · 39 citations · Full text

Distinguishing Aspartic and Isoaspartic Acids in Peptides by Several Mass Spectrometric Fragmentation Methods

Nick DeGraan-Weber, Jun Zhang, James P. Reilly · Journal of the American Society for Mass Spectrometry · 2016 · 35 citations · Full text

Advancing Structure Characterization of PS-80 by Charge-Reduced Mass Spectrometry and Software-Assisted Composition Analysis

Rong‐Sheng Yang, David R. Bush, Nick DeGraan-Weber et al. · Journal of Pharmaceutical Sciences · 2021 · 13 citations · Full text

Analytical Instrumentation, Biochemistry, Software-assisted Composition Analysis +12

Attribute Analytics Performance Metrics from the MAM Consortium Interlaboratory Study

Trina Mouchahoir, John E. Schiel, Rich Rogers et al. · Journal of the American Society for Mass Spectrometry · 2022 · 13 citations · Full text

Business Intelligence, Biological Mass Spectrometry, Performance Measurement +27

Rows per page

1–4 of 4